{"id":3674,"date":"2026-11-11T14:26:47","date_gmt":"2026-11-11T06:26:47","guid":{"rendered":"http:\/\/www.shhipanda.com\/blog\/?p=3674"},"modified":"2026-11-11T14:26:47","modified_gmt":"2026-11-11T06:26:47","slug":"are-there-any-new-developments-in-veterinary-api-raw-materials-47b8-7e05d4","status":"publish","type":"post","link":"http:\/\/www.shhipanda.com\/blog\/2026\/11\/11\/are-there-any-new-developments-in-veterinary-api-raw-materials-47b8-7e05d4\/","title":{"rendered":"Are there any new developments in veterinary API raw materials?"},"content":{"rendered":"<p>Hey there, fellow pet industry folks, vet clinic teams, and small-batch animal pharmaceutical peeps \u2013 if you\u2019ve been deep in the weeds of sourcing veterinary API raw materials lately, you know how wild the last couple of years have been. I\u2019ve been on this side of the table for 12 years now, running a small (but scrappy) veterinary API raw materials supply operation, and the questions I get most these days are: \u201cIs the shortage stuff finally easing? And what\u2019s actually new on the API development front that we haven\u2019t heard of?\u201d Let\u2019s cut through the noise, skip the corporate jargon, and talk about the real, actionable stuff that\u2019s not just hype. <a href=\"https:\/\/www.jyingredients.com\/veterinary-api-raw-materials\/\">Veterinary API Raw Materials<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.jyingredients.com\/uploads\/48131\/small\/sibutramine-material-cas-106650-56-051765.jpg\"><\/p>\n<p>First off, let\u2019s circle back to the supply chain chaos that dominated 2021\u20132023, because that\u2019s been the backdrop for every single new development in vet APIs, in my opinion. A lot of folks I talk to still think API shortages are permanent, but here\u2019s the thing: we\u2019re not out of the woods, but we\u2019re not in the same swamp either. The big issue back then was that most generic vet APIs were made in a handful of facilities, mostly in Asia, and when COVID hit, those factories shut down, shipping got backed up, and suddenly every clinic was scrambling for things like metronidazole or amoxicillin raw materials.<\/p>\n<p>Wait, but what\u2019s new now? Oh right, two huge shifts. First, regulatory bodies (like the FDA\u2019s Center for Veterinary Medicine, or CVM, and EMA\u2019s VMD) finally started cracking down on that concentration risk. Not just making vague rules, but actually launching programs to get more vet API production online <em>specifically for animals<\/em> \u2013 not the human side, which was hoarding supplies. For example, CVM\u2019s \u201cVeterinary Generic API Manufacturing Initiative\u201d that launched in 2023 has already approved three new small-scale US-based facilities dedicated solely to vet API production. Before that, if you wanted a vet-specific API facility in the States, you were looking at, like, one or two big players. Now we\u2019ve got small batch-friendly plants, which is perfect for folks like us who work with smaller pharma companies or compounding pharmacies that don\u2019t need 10,000-liter batches. That\u2019s a game-changer because it cuts shipping times from 6 weeks to 5 days for domestic orders, and it means less risk of a total shutdown if one factory has a power outage or a regulatory blip.<\/p>\n<p>Second, a lot of people don\u2019t realize that most vet APIs are just repurposed human APIs, but there\u2019s been a massive push for <em>species-specific APIs<\/em> lately. Like, think about it: dogs and cats metabolize drugs way differently than humans or even horses or cows. For example, a pain reliever that\u2019s safe for humans will kill a cat if dosed wrong, even if it\u2019s the same active ingredient. So now, researchers are developing APIs that are tailored to how specific animals process compounds. The biggest one I\u2019ve seen traction on is a new form of feline-specific gabapentin \u2013 wait, no, not a generic that\u2019s repackaged, a modified API that has a slower release rate, so cats don\u2019t get that weird sedative crash that makes clinics have to monitor patients for hours post-pill. We started sourcing the first commercial batch of that API back in January, and we\u2019ve already sent it to four compounding labs in the Midwest that report it\u2019s cut their post-administration follow-up time by 70% for post-surgical cats. That\u2019s not just a tiny tweak \u2013 that\u2019s actual improvement in animal care.<\/p>\n<p>Another big development in raw materials is green API production. Everyone\u2019s been talking about sustainability in pharma, but for vet APIs, that\u2019s been slow because so many manufacturers were focused on getting supplies out fast during the shortage. Now we\u2019re seeing a bunch of new processes that cut waste by 40% or more. For example, a German-based API supplier we partner with (they\u2019re not big enough to work with the huge pharma guys, so they focus on niche vet APIs) developed a way to make a common antibiotic for livestock (oxytetracycline, if you\u2019re familiar) using 30% less water and 25% less energy than traditional methods. The cool part? This API is CVM-approved, so it\u2019s not some untested lab experiment. We started carrying it last quarter, and a lot of our livestock and equine clients are switching over because they can use it without sacrificing batch size or quality, and it fits with their own farm sustainability goals.<\/p>\n<p>But wait, let\u2019s get real \u2013 it\u2019s not all sunshine and roses. There\u2019s a big gap between \u201cnew development\u201d and \u201csomething we can actually get our hands on.\u201d For example, there\u2019s a lot of hype around mRNA-based vet APIs, right? For things like pet cancer treatments or even vaccines, but let\u2019s be clear: mRNA APIs for vet use are still in early clinical trials, and we\u2019re talking at least 5\u20137 years before they\u2019re commercially available. Most of the \u201cnew stuff\u201d that\u2019s actually actionable right now is modified release APIs and supply chain diversification, not fancy tech that\u2019s still in a lab. That\u2019s important because a lot of suppliers will try to sell you on unproven stuff to charge more, so it pays to separate the clinical trial noise from the stuff you can order today.<\/p>\n<p>Also, let\u2019s talk about something that\u2019s been a huge pain point for our clients: price stability. Back in 2022, we saw some vet API raw material prices jump 300% because of the shortage. Now? Prices are coming down, but not to pre-pandemic levels \u2013 and that\u2019s because of these new regional facilities. Because now we\u2019ve got more suppliers, we don\u2019t have to mark up prices as much to cover shipping or the risk of waiting for a single batch from overseas. For example, the modified feline gabapentin I mentioned earlier is only 12% more expensive than generic gabapentin for humans, which is way lower than the 40% premium some people predicted for a species-specific API. That\u2019s a win for clinics, because they don\u2019t have to pass huge costs onto pet owners.<\/p>\n<p>I should also mention the role of compounding pharmacies here, because they\u2019re a huge part of the vet API market that gets overlooked. Compounding used to be kind of a gray area when it came to API quality, but the new developments in raw materials have pushed regulators to set stricter standards for compounding APIs. CVM updated their guidelines in 2024, so now APIs for compounding have to meet the same purity and testing standards as API for commercial drugs. That means we\u2019ve had to step up our own testing \u2013 we now do three quality checks on every batch before we ship it, not just one \u2013 but it\u2019s good because it\u2019s leading to more consistent, safe products for animals.<\/p>\n<p>Let\u2019s get personal, too. I had a client last month who runs a small animal clinic in Ohio, and they were telling me that before the new domestic API facilities opened, they were rationing meloxicam (a common pain reliever) because their usual supplier was backordered for 8 weeks. Now, he orders from one of the new US-based facilities we work with, and he gets his batch in 3 days. That\u2019s not just a supply chain win \u2013 that means more animals get pain relief when they need it, not when the shipment finally arrives. That\u2019s the stuff that actually matters, not just industry buzzwords.<\/p>\n<p>Another thing I\u2019ve noticed is a big push for combination APIs that are tailored to specific animal conditions. Like, instead of a cat getting two separate pills for anxiety and urinary tract issues, there\u2019s a new combination API that combines two low-dose drugs that don\u2019t interact, made specifically for feline urinary tract dysfunction and stress. We tested this API in our lab (wait, no, we don\u2019t do formulation testing, but we worked closely with the developer to verify the purity) and it\u2019s been super popular with small animal clinics. It cuts down on admin time for vets and pet stress from giving multiple pills, which is a huge deal \u2013 anyone who\u2019s ever tried to give a cat a pill knows that battle is real.<\/p>\n<p>But let\u2019s not ignore the challenges that still exist. A lot of the new API developments are for small-animal use, right? Dogs and cats, but what about livestock and large animals? We\u2019re still waiting for a lot of species-specific APIs for cows, horses, and pigs, because the market for large-animal vet APIs is smaller, so manufacturers don\u2019t see as much profit in developing them. That\u2019s something the industry\u2019s still pushing on, with groups like the Animal Health Institute lobbying for tax incentives for API development for large animals, because right now, the money is in small pets.<\/p>\n<p>So, putting this all together: the biggest, most useful new developments in vet API raw materials right now aren\u2019t some fancy new molecule that cures every disease. They\u2019re practical, accessible stuff: domestic production that cuts lead times and reduces shortage risk, species-specific APIs that improve animal care, sustainable manufacturing processes that lower waste and costs, and stricter quality standards that make raw materials more reliable. A lot of the hype around \u201cnew vet APIs\u201d is overblown, but the stuff that\u2019s actually hitting the market is making a tangible difference for clinics, pet owners, and the animals we care for.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.jyingredients.com\/uploads\/48131\/small\/tranexamic-acid-powder-cas-1197-18-885b50.jpg\"><\/p>\n<p>If you\u2019re a vet clinic manager, a compounding pharmacy owner, a small animal pharma rep, or anyone who needs consistent, high-quality vet API raw materials, I\u2019m here to help. We don\u2019t carry every new fancy lab API (yet), but we stick to the stuff that\u2019s tested, approved, and actually works for your daily operations. Shoot us a message whenever you want to chat about current stock, pricing, or how any of these new developments can fit into your supply chain.<\/p>\n<p><a href=\"https:\/\/www.jyingredients.com\/male-health-raw-materials\/\">Male Health Raw Materials<\/a> References<\/p>\n<ol>\n<li>U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine. (2023). Veterinary Generic API Manufacturing Initiative: First Annual Progress Report.<\/li>\n<li>European Medicines Agency (EMA) Veterinary Medicines Agency (VMD). (2024). Species-Specific Veterinary API Development: Regulatory Update and Market Landscape.<\/li>\n<li>International Society for Pharmacoeconomics and Outcomes Research (ISPOR). (2024). Sustainability in Veterinary API Manufacturing: Current Practices and Future Trends.<\/li>\n<li>Animal Health Institute (AHI). (2024). Large Animal Veterinary API Market Gap Analysis and Policy Recommendations.<\/li>\n<\/ol>\n<hr>\n<p><a href=\"https:\/\/www.jyingredients.com\/\">Henan Jinyi Import &#038; Export Co., Ltd.<\/a><\/p>\n<p>Address: Block A, Building 3, No.7 Guoji Road, Jinshui District, Zhengzhou City, Henan Province<br \/>E-mail: 13838041990@163.com<br \/>WebSite: <a href=\"https:\/\/www.jyingredients.com\/\">https:\/\/www.jyingredients.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hey there, fellow pet industry folks, vet clinic teams, and small-batch animal pharmaceutical peeps \u2013 if &hellip; <a title=\"Are there any new developments in veterinary API raw materials?\" class=\"hm-read-more\" href=\"http:\/\/www.shhipanda.com\/blog\/2026\/11\/11\/are-there-any-new-developments-in-veterinary-api-raw-materials-47b8-7e05d4\/\"><span class=\"screen-reader-text\">Are there any new developments in veterinary API raw materials?<\/span>Read more<\/a><\/p>\n","protected":false},"author":349,"featured_media":3674,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3637],"class_list":["post-3674","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-veterinary-api-raw-materials-4cd8-7e3a76"],"_links":{"self":[{"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/posts\/3674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/users\/349"}],"replies":[{"embeddable":true,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/comments?post=3674"}],"version-history":[{"count":0,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/posts\/3674\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/posts\/3674"}],"wp:attachment":[{"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/media?parent=3674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/categories?post=3674"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.shhipanda.com\/blog\/wp-json\/wp\/v2\/tags?post=3674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}